Elevance Health (NYSE:ELV) Price Target Lowered to $500.00 at Truist Financial
Elevance Health (NYSE:ELV – Free Report) had its target price cut by Truist Financial from $510.00 to $500.00 in a research report released on Monday morning,Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages also recently commented on ELV. Guggenheim restated a “buy” rating and issued a $518.00 […]
Elevance Health (NYSE:ELV – Free Report) had its target price cut by Truist Financial from $510.00 to $500.00 in a research report released on Monday morning,Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages also recently commented on ELV. Guggenheim restated a “buy” rating and issued a $518.00 […]
